Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409136 · ClinicalTrials.gov registry record
Multi-Center Human Alert Trial to Prevent DVT and PE
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 2,496
- Enrollment target
NCT00409136: Completed study, sponsored by Brigham and Women's Hospital.
NCT00409136 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,496 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00409136 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 2,496 participants
- Enrollment target
Study Summary
To evaluate physician response to human alerts that inform the clinician that his/her patient may be eligible for thromboprophylaxis. Medical records are reviewed to evaluate prescribing decision and to evaluate rates of venous thromboembolism.
Interventions
- BEHAVIORAL Human Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,496 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-08 |
What the finished NCT00409136 record still lists
NCT00409136 is an observational study that tracks outcomes without assigning an intervention. Its 2,496 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Human Alert is the first listed.
NCT00409136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00409136 about?
NCT00409136 is a clinical study titled "Multi-Center Human Alert Trial to Prevent DVT and PE". To evaluate physician response to human alerts that inform the clinician that his/her patient may be eligible for thromboprophylaxis. Medical records are reviewed to evaluate prescribing decision and to evaluate rates of venous thromboembolism.
What is the current status of trial NCT00409136?
This trial is currently completed. The enrollment target is 2,496 participants. The study started on 2006-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00409136?
The interventions under investigation include: Human Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT00409136?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia